[PDF][PDF] Structure, recognition, and processing of cisplatin− DNA adducts
ER Jamieson, SJ Lippard - Chemical reviews, 1999 - Citeseer
In the course of examining the effect of electric fields on the growth of Escherichia coli cells,
a biological activity of platinum compounds was uncovered that led to the development of …
a biological activity of platinum compounds was uncovered that led to the development of …
How do chemotherapeutic agents damage the ovary?
S Morgan, RA Anderson, C Gourley… - Human reproduction …, 2012 - academic.oup.com
BACKGROUND Chemotherapy treatment in premenopausal women is associated with an
increased risk of premature ovarian failure (POF) but the exact mechanism through which …
increased risk of premature ovarian failure (POF) but the exact mechanism through which …
Cisplatin and oxaliplatin: our current understanding of their actions
IA Riddell, SJ Lippard - Met. Ions Life Sci, 2018 - degruyter.com
Following the serendipitous discovery of the anticancer activity of cisplatin over 50 years
ago, a deep understanding of the chemical and biochemical transformations giving rise to its …
ago, a deep understanding of the chemical and biochemical transformations giving rise to its …
Tumour-inhibiting platinum complexes—state of the art and future perspectives
MA Jakupec, MS Galanski, BK Keppler - Reviews of physiology …, 2003 - Springer
Thirty years after the onset of the first clinical studies with cisplatin, the development of
antineoplastic platinum drugs continues to be a productive field of research. This article …
antineoplastic platinum drugs continues to be a productive field of research. This article …
[HTML][HTML] How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models
MW van Gisbergen, AM Voets, MHW Starmans… - … Research/Reviews in …, 2015 - Elsevier
Several mutations in nuclear genes encoding for mitochondrial components have been
associated with an increased cancer risk or are even causative, eg succinate …
associated with an increased cancer risk or are even causative, eg succinate …
[PDF][PDF] Targeting mitochondrial DNA with a platinum-based anticancer agent
An analog of the anticancer drug cisplatin (mtPt) was delivered to mitochondria of human
cells using a peptide specifically targeting this organelle. mtPt induces apoptosis without …
cells using a peptide specifically targeting this organelle. mtPt induces apoptosis without …
Doxorubicin and cisplatin induced cognitive impairment: the possible mechanisms and interventions
B Ongnok, N Chattipakorn, SC Chattipakorn - Experimental neurology, 2020 - Elsevier
Chemotherapy has significantly increased the number of cancer survivors. However,
chemotherapy itself carries various adverse effects that limit the efficacy of treatment and …
chemotherapy itself carries various adverse effects that limit the efficacy of treatment and …
Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell …
Z Yang, LM Schumaker, MJ Egorin, EG Zuhowski… - Clinical cancer …, 2006 - AACR
Purpose: Cisplatin adducts to nuclear DNA (nDNA) are felt to be the molecular lesions that
trigger apoptosis, but the mechanism linking nDNA adduct formation and cell death is …
trigger apoptosis, but the mechanism linking nDNA adduct formation and cell death is …
Subcellular targets of cisplatin cytotoxicity: an integrated view
SM Sancho-Martínez, L Prieto-García, M Prieto… - Pharmacology & …, 2012 - Elsevier
Cisplatin is a chemotherapeutic drug widely used against a variety of cancers. Its clinical
utility is severely limited by its toxicity, which mainly affects, but is not limited to, the inner ear …
utility is severely limited by its toxicity, which mainly affects, but is not limited to, the inner ear …
Sequence-and region-specificity of oxaliplatin adducts in naked and cellular DNA
JM Woynarowski, WG Chapman, C Napier… - Molecular …, 1998 - ASPET
Oxaliplatin is a clinical anticancer drug with a pharmacological profile distinct from that of
cisplatin. Our studies compared site-and region-specificity of lesions induced by oxaliplatin …
cisplatin. Our studies compared site-and region-specificity of lesions induced by oxaliplatin …